IL17A and Parkinson disease: KEGG pathway analysis demonstrated that the candidate targets were primarily enriched in inflammation-related signaling pathways, including MAPK, TNF, IL-17, Toll-like receptor, NF-κB pathways, as well as pathways associated with Parkinson’s disease (Figure 4B).